Noel Hall

Mr. Hall offers extensive experience in the technology and biotechnology sectors, with particular expertise in deal making, strategic planning and market development. Known as a visionary who sees a clear path to success, Mr Hall has proven ability to drive research-based technology into profitable commercialization.

As a serial entrepreneur, Mr. Hall was co-founder and president of Aspreva Pharmaceuticals, taking the company from start-up to profitability and over a billion dollar market cap in seven years. He is also the co-founder and board chair of Creatus Biosciences, co-founder and board director of Arius Technology, co-founder and board chair of Melio Peptide systems. In, addition Mr Hall sits on the board of Epistemics AI. He is also currently the CEO and Chairman of Bast Fibre Technologies. Mr Hall is currently a Creative Destruction Lab (CDL) mentor with CDL rockies stream.

He was also the co-founder and Chairman for Vitaeris Bio which was sold to CSL Behring in June 2020 as well as co former board director for Zymeworks.

Prior to moving to Canada from London in 1997 Mr Hall held a number senior executive positions in the pharmaceutical industry.

Mr. Hall is currently a director of Machall Investments, a family office focused on the Healthcare, Technology and sustainability sectors .